Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting…

Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis

 

Conducted for the British Columbia Ministry of Health

Tricco, A. C., Antony, J., Khan, P. A., Ghassemi, M., Hamid, J. S., Ashoor, H., ... & Hemmelgarn, B. R. (2014). Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: A systematic review and network meta-analysis. BMJ Open, 4(12), e005752. doi: 10.1136/bmjopen-2014-005752.

 

Impact:

  • Influenced the decision to delist DPP-4 inhibitors for T2DM patients in British Columbia
Printer Friendly

Category :

Date : 22 Mar 2016